Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
-5,602
Period ended Jun 30, 2026
Change on a year earlier
+627.5%
-770 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
60
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Cash Used in Investing Activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -5,602 | +627.5% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | -10,210 | +586.6% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | -11,201 | +675.7% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | -283 | -92.6% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | -770 | -28.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | -1,487 | +8.1% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | -1,444 | -2,824.5% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | -3,845 | +1,051.2% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | -1,069 | -90.7% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | -1,376 | -41.7% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 53 | -103.0% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | -334 | -65.3% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | -11,443 | +962.5% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | -2,359 | +101.1% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | -1,748 | -85.5% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | -962 | -9.3% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | -1,077 | -59.0% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | -1,173 | +71.0% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | -12,049 | +156.5% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | -1,061 | -49.1% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | -2,625 | +235.7% | Form 10-Q (filed 2022-05-05) ↗ |
| Q1 2021 | Mar 31, 2021 | -686 | -57.9% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | -4,697 | +608.4% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | -2,086 | -1,192.1% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | -782 | -67.8% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2020 | Mar 31, 2020 | -1,628 | -542.4% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | -663 | -130.4% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 191 | -88.5% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | -2,425 | -460.3% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 368 | -286.8% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 2,178 | -3,855.2% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 1,660 | +147.4% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 673 | -159.7% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | -197 | -106.2% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | -58 | -97.7% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 671 | -175.4% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | -1,127 | -24.8% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 3,193 | +83.4% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | -2,563 | +315.4% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | -890 | +1,359.0% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | -1,498 | -159.3% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 1,741 | -126.4% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | -617 | -108.6% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | -61 | -98.4% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 2,525 | -5,253.1% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | -6,605 | +73.5% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 7,204 | – | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | -3,722 | +17.3% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | -49 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | -3,807 | +230.2% | Form 10-Q (filed 2014-05-08) ↗ |
| Q2 2013 | Sep 30, 2013 | -3,172 | +72.5% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | -1,153 | +327.0% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | -4,398 | +161.2% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | -1,839 | +599.2% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | -298 | – | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | -270 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | -1,684 | +67.2% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | -263 | -235.6% | Form 10-Q (filed 2011-11-08) ↗ |
| Q4 2010 | Dec 31, 2010 | -1,007 | -92.2% | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | 194 | -98.4% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 464 | -82.3% | Form 10-Q (filed 2011-08-08) ↗ |
| Q1 2010 | Mar 31, 2010 | -3,148 | -326.5% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2009 | Dec 31, 2009 | -12,865 | +709.1% | Form 10-Q (filed 2010-11-08) ↗ |
| Q3 2009 | Sep 30, 2009 | 12,012 | +14,031.3% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 2,619 | – | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | 1,390 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2008 | Dec 31, 2008 | -1,590 | – | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2008 | Sep 30, 2008 | 85 | – | Form 10-Q (filed 2009-10-29) ↗ |
Cite this data
StockData. (2026). Merck Net Cash Used in Investing Activities ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_cf_icf
See every metric in the Merck KPI table. Data updated Oct 26, 2026.